FiercePharmaPolitics—States still exploring drug pricing despite congressional gridlock

FiercePharmaPolitics—States still exploring drug pricing despite congressional gridlock

Source: 
Fierce Pharma
snippet: 

Drug pricing legislation hasn’t gained any steam in Congress lately, but legislatures in dozens of states are chugging ahead.

States nationwide are advancing bills focused on numerous topics, a new analysis from Deloitte found. Legislation to regulate pharmacy benefit managers is the most common, the experts found, while many states have passed—or are considering—measures such as transparency requirements for price increases, importation, value-based contracting and more.